Balancing Risk and Reward in Target Delineation for Highly Conformal Radiotherapy in Head and Neck Cancer

Seminars in Radiation Oncology

Volumn 19, Issue 1, 2009, Pages 43-52

  Eisbruch, Avraham ^a   Gregoire, Vincent ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

CANCER CHEMOTHERAPY; CLINICAL DECISION MAKING; COMPUTER ASSISTED RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; LARYNX CANCER; LYMPH NODE METASTASIS; NASOPHARYNX CANCER; ORGAN; OROPHARYNX CANCER; PRIORITY JOURNAL; REVIEW; REWARD; RISK; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56349088377     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2008.09.008     Document Type: Review

References (79)

1. Hong T.S., Chappell R.J., and Harari P.M. Variations in target delineation for head and neck IMRT: An international multi-institutional study. Int J Radiat Oncol Biol Phys 60 (2004) S157
2. Som P.M. The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR Am J Neuroradiol 18 (1997) 1869-1872
3. Ahn P.H., and Garg M.K. Positron emission tomography/computed tomography for target delineation in head and neck cancers. Semin Nucl Med 38 (2008) 141-148
4. Rasch C., Eisbruch A., Reimeijer P., et al. Irradiation of paranasal sinus tumors, a delineation and dose comparison study. Int J Radiat Oncol Biol Phys 52 (2002) 120-127
5. Chao K.S., Bhide S., Chen H., et al. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phy 68 (2007) 1512-1521
6. Jeanneret-Sozzi W., Moeckli R., Valley J.F., et al. The reasons for discrepancies in target volume delineation: A SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol 182 (2006) 450-457
7. Steenbakkers R.D.J., Fitton I., Deurloo K., et al. Observer variation in delineation of nasopharyngeal carcinoma for radiotherapy: A 3-D analysis. Int J Radiat Oncol Biol Phys 60 (2004) S160
8. Geets X., Daisne J.F., Arcangeli S., et al. Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: Comparison between CT-scan and MRI. Radiother Oncol 77 (2005) 25-31
9. Ashamalla H., Rafla S., Parikh K., et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1016-1023
10. Ciernik I.F., Dizendorf E., Baumert B.G., et al. Radiation treatment planning with integrated CT/PET. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
11. Syed R., Bomanji J.B., Nagabhushan N., et al. Impact of combined FDG PET/CT in head and neck tumors. Br J Cancer 92 (2005) 1046-1050
12. Daisne J.F., Duprez T., Weynand B., et al. Accuracy of CT scan. MRI and FDG-PET in delineating the tumor volume in pharyngo-laryngeal squamous cell carcinomas treated by radiotherapy: Validation with the macroscopic tumor specimen used as reference. Radiology 233 (2004) 93-100
13. Geets X., Daisne J.F., Tomsej M., et al. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies. Radiother Oncol 78 (2006) 291-297
14. Paulino A.C., Koshy M., Howell R., et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1385-1392
15. Schwartz D.L., Ford E.C., Rajendran J., et al. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation. Head Neck 27 (2005) 478-487
16. Schingal D.A., Vogel W.V., Hoffmann A.L., et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1282-1289
17. Gregoire V., Daisne J.F., and Geets X. Comparison of CT- and FDG-PET-defined GTV. Int J Radiat Oncol Biol Phys 63 (2005) 308-309
18. Geets X., Lee J., Bol A., et al. A gradient-based method for segmenting FDG-PET images: Methodology and validation. Eur J Nucl Med Mol Imaging 34 (2007) 1427-1438
19. Grégoire V., Daisne J.F., Geets X., et al. Selection and delineation of target volumes in head and neck tumors. Rays 28 (2003) 217-224
20. Soto D., Piert M., and Eisbruch A. Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy of head and neck cancer. Radiother Oncol (2008) Jun 12; [Epub ahead of print]
21. Scarfone C., Lavely W.C., Cmelak A.J., et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45 (2004) 543-552
22. Wang D., Schultz C.J., Jursinic P.A., et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 143-151
23. Madani I., vanderstraeten B., Bral S., et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 126-135
24. Vineberg K.A., Eisbruch A., Coselmon M.M., et al. Is uniform target dose possible in IMRT plans in the head and neck?. Int J Radiat Oncol Biol Phys 52 (2002) 1159-1172
25. Tome W.A., and Fowler J.F. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 48 (2000) 593-599
26. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
27. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
28. Geets X., Tomsej M., Lee J.A., et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: Impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85 (2007) 105-115
29. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24 (2002) 127-135
30. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
31. Lee N.Y., Mechalakos J.G., Nehmeh S., et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: A feasibility study. Int J Radiat Oncol Biol Phys 70 (2008) 2-13
32. Alber M., Paulsen F., Eschmann S.M., et al. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
33. Grosu A.L., Souvatzoglou M., Rpoer B., et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 541-551
34. Nehmeh S.A., Lee N.Y., Schroder H., et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 235-242
35. Thorwarth D., Eschmann S.M., Holzner F., et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol Biol Phys 68 (2007) 515-521
36. O'Sullivan B., Warde P., Grice B., et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 51 (2001) 332-343
37. Lin C.Y., Lee L.Y., and Huang S.F. Treatment outcome of combined modalities for buccal cancers: Unilateral or bilateral neck radiation?. Int J Radiat Oncol Biol Phys 68 (2007) 750-757
38. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
39. Chao K.S., Wippold F.J., Ozygit G., et al. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53 (2002) 1174-1184
40. Lee N., Xia P., Fischbein N.J., et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 57 (2003) 49-60
41. Eisbruch A., Marsh L., Dawson L.A., et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
42. Yao M., Chang K., Funk G.F., et al. The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the university of Iowa experience. Int J Radiat Oncol Biol Phys 67 (2007) 1332-1341
43. Gregoire V., Coche E., Cosnard G., et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
44. Eisbruch A., Foote R.L., O'Sullivan B., et al. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12 (2002) 238-249
45. Grégoire V., Levendag P., Ang K.K., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA. EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69 (2003) 227-236
46. Grégoire V., Eisbruch A., Hamoir M., et al. Proposal for the delineation of the nodal CTV in the node positive and the post-operative neck. Radiother Oncol 79 (2006) 15-20
47. Som P.M., Curtin H.D., and Mancuso A.A. An image-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classification. Arch Otolaryngol Head Neck Surg 125 (1999) 388-396
48. Rouviere H. Lymphatic Systems of the Head and Neck (1938), Edwards Brothers, Ann Arbor, MI
49. Murdoch-Kinch M.A., Kim H.M., Vineberg K., et al. Dose-response relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Rad Onc Biol Phys 72 (2008) 373-382
50. Cannon D.M., and Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 660-665
51. Proctor B. Embryology and anatomy of the eustachian tube. Arch Otolaryngol 86 (1967) 503-514
52. Ng S.H., Chang J.T., Chan S.C., et al. Nodal metastases of nasopharyngeal carcinoma: Patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging 31 (2004) 1073-1080
53. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration following chemo-irradiation of head and neck cancer: Which anatomical structures are affected, and can they bespared by IMRT?. Int J Rad Onc Biol Phys 60 (2004) 1425-1439
54. Feng F., Kim H.M., Lyden T., et al. IMRT of head and neck cancer aiming at reducing dysphagia: Early dose-volume-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68 (2007) 1289-1298
55. Fisch U. Cervical lymph flow following surgery in the neck. In: Fisch U. (Ed). Lymphography of the Cervical Lymphatic System (1968), WB Saunders, Philadelphia 112-141
56. Amdur R.J., Li J.G., Hinerman R.W., et al. Unnecessary laryngeal irradiation in the IMRT era. Head Neck 26 (2004) 257-263
57. Dabaja B.S., Suki D., Bonnen M., et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: Comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63 (2005) 1000-1005
58. Lee N., Mechalakos J., Puri D.R., et al. Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1299-1309
59. Thorstad W., Nussenbaum B., Adkins D.R., et al. Recurrences in the low neck after IMRT of head and neck cancer. ASTRO 2008. Int J Radiat Oncol Biol Phys 72 Suppl 1 (2008) S387 (Abstr. 2488), 2008
60. Khuntia D., Harris J., Bentzen S.M., et al. Comparisons of mucositis between IMRT and conventional RT in an RTOG study of post-operative chemotherapy or cetuximab-chemotherapy. ASTRO 2008. Int J Radiat Oncol Biol Phys 72 Suppl 1 (2008) S33 (Abstr. 70)
61. Eisbruch A. Reducing xerostomia by IMRT: What can, and cannot, be achieved. J Clin Oncol 25 (2007) 4863-4864
62. Lee N., Chuang C., Quivey J.M., et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 53 (2002) 630-637
63. Sanguineti G., Endres E.J., Gunn B.G., et al. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?. Int J Radiat Oncol Biol Phys 66 (2006) 931-938
64. Fua T.F., Corry J., Milner A.D., et al. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys 67 (2007) 976-981
65. Koom W.S., Kim T.H., Shin K.H., et al. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas. Head Neck 30 (2008) 159-169
66. Guerrero Urbano T., Clark C.H., Hansen V.N., et al. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother Oncol 85 (2007) 36-41
67. Lauve A., Morris M., Schmidt-Ullrich R., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II-Clinical results. Int J Radiat Oncol Biol Phys 60 (2004) 374-387
68. Mazeron J.J., Simon J.M., Le Péchoux C., et al. Effect of dose rate on local control and complications in irradiation of T1-2 carcinomas of tongue and floor of mouth with interstitial iridium-192. Radiother Oncol 21 (1991) 39-47
69. Lee I., and Eisbruch A. The dose-equivalent increase of mucositis by adding concurrent chemotherapy to irradiation of head and neck cancer. ASTRO 2008. Int J Radiat Oncol Biol Phys 72 Suppl 1 (2008) S157 (Abstr. 1098)
70. Amosson C.M., The B.S., Garg A.K., et al. Accelerated fractionation for head and neck cancer using the SMART boost technique. Int J Radiat Oncol Biol Phys 57 (2003) S306 (abstr 1076)
71. Posner M.R., Hershok D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
72. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
73. Posner M. Evolving strategies for combined modality therapy for locally advanced head and neck cancer. Oncologist 12 (2007) 967-974
74. Tannock I.F. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 16 (1989) 83-101
75. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radio resistance. Nat Rev Cancer 8 (2008) 545-554
76. Eisbruch A. Commentary: Induction chemotherapy for head and neck cancer: Hypothesis-based rather than evidence-based medicine. Oncologist 12 (2007) 975-977
77. Woodford C., Yartsev S., Dar A.R., et al. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys 69 (2007) 1316-1322
78. Klug C., Keszthelyi D., Ploder O., et al. Neoadjuvant radiochemotherapy of oral cavity and oropharyngeal cancer: Evaluation of tumor response by CT differs from histopathologic response assessment in a significant fraction of patients. Head Neck 26 (2004) 224-231
79. Konski A.A., Cheng J.D., Goldberg M., et al. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys 69 (2007) 358-363